Comparison of the absorption of magnesium citrate and magnesium oxide in healthy subjects.
Not Applicable
Completed
- Conditions
- Absorption of magnesium.Diet and Nutrition - Other diet and nutrition disorders
- Registration Number
- ACTRN12615001268538
- Lead Sponsor
- Verla-Pharm Arzneimittel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Male Caucasians aged between 18 and 45 years (including) in general good physical health and normal weight with normal renal function.
Exclusion Criteria
Any illnesses or medication with influence on renal function.
More than moderate alcohol consumption or history of alcohol abuse.
Supplementation with magnesium.
Symptoms of magnesium deficiency.
Any gastrointestinal complaints.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of magnesium excreted into the urine.<br>[Timepoint: within 24 h after intervention.]
- Secondary Outcome Measures
Name Time Method Magnesium concentration in monocytes/lymphocytes (explorative evaluation).[Timepoints: predose, 9 h and 24 h post dose.];Magnesium concentration in erythrocytes (explorative evaluation).[Predose, 9 h and 24 h post dose];Magnesium concentration in serum (explorative evaluation).[Predose, 60 min, 2 h, 3 h, 4 h, 5 h, 6 h, 9 h and 24 h post dose.]